Skip to content
StockMarketAgent
Healthcare / Medical Care FacilitiesUpdated 2026-05-10 22:07 UTC

MCTA stock hub

Charming Medical Limited has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

MCTAis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
504.3M
NASDAQ
Market data

Live price

Current market quote for this ticker.

Current price
MCTA
In the news

Latest news · MCTA

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 12.3P50 18.4P75 33.1
Trailing P/E767.2
P25 14.9P50 23.2P75 38.5
ROEn/a
P25 -105.6P50 -46.5P75 -3.1
ROIC71.8
P25 -63.1P50 -27.3P75 0.5
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All MCTA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
163
Groups with data
11
Currency
USD
Showing 163 of 163 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

24
MetricValue
Cik
0002035992
Company name
Charming Medical Limited
Country
Hong Kong
Country code
US
Cusip
G20528108
Employees
49
Employees Change
0%
Employees Change Percent
0
Enterprise value
$502.7M
Exchange
NASDAQ
Financial currency
USD
First seen
2026-05-09
Industry
Medical Care Facilities
IPO Date
2025-10-21
Isin
VGG205281089
Last refreshed
2026-05-10
Market cap
$504.3M
Market cap category
Small-Cap
Price
$29.11
Price currency
USD
Rev Per Employee
110,677.1x
Sector
Healthcare
Sic
8090
Symbol
MCTA

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

10
MetricValue
Earnings Yield
0.13%
EV Earnings
764.75x
EV/EBIT
545.52x
EV/EBITDA
435.66x
EV/FCF
1,252.69x
EV/Sales
92.69x
FCF yield
0.08%
P/B ratio
1,408.66x
P/E ratio
767.18x
P/S ratio
92.98x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

17
MetricValue
EBIT Margin
16.99%
EBITDA Margin
21.28%
FCF margin
7.4%
Gross margin
96.02%
Gross Profit
$5.2M
Gross Profit Growth
-15.09%
Gross Profit Growth Q
-20.19%
Net Income
$657,290
Net Income Growth
-24.65%
Net Income Growth Years
1%
Pretax Margin
15.4%
Profit Margin
12.12%
Profit Per Employee
$13,414
Profitable Years
2
ROA
10.64
ROCE
198.5
ROIC
71.76

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

9
MetricValue
EPS Growth
-24.65
EPS Growth Years
1
FCF Growth
3,823.58%
FCF Growth Q
162.1%
OCF Growth
266.71%
OCF Growth Q
76.08%
Revenue Growth
-14.36x
Revenue Growth Q
-26.99x
Revenue Growth Years
1x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

21
MetricValue
Asset Turnover
$1
Assets
$5.5M
Cash
$2.7M
Current Assets
$2.9M
Current Liabilities
$5M
Debt
$573,364
Debt EBITDA
$0.31
Debt Equity
$1.6
Debt FCF
$1.43
Equity
$357,972
Interest Coverage
44.82
Liabilities
$5.1M
Long Term Assets
$2.5M
Long Term Liabilities
$106,285
Net Cash
$2.1M
Net Cash By Market Cap
$0.42
Net Debt EBITDA
$-1.83
Net Debt Equity
$-5.9
Net Debt FCF
$-5.27
Tangible Book Value
$357,972
Tangible Book Value Per Share
$0.02

Liquidity

Current-asset coverage and working-capital efficiency metrics.

5
MetricValue
Current ratio
0.59
Inventory Turnover
2.92
Net Working Capital
$-4.3M
Quick ratio
0.57
Working Capital
$-2.1M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Dividend Yield
0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

20
MetricValue
All Time High
31.7
All Time High Change
-8.17%
All Time High Date
2025-11-11
All Time Low
4.3
All Time Low Change
576.98%
All Time Low Date
2025-10-21
ATR
4.16
Beta1y
1.2
High52
31.7
High52 Date
2025-11-11
High52ch
-8.17%
Low52
4.3
Low52 Date
2025-10-21
Low52ch
576.98%
RSI
81.33
RSI Monthly
0
RSI Weekly
0
Sharpe ratio
9.5x
Sortino ratio
33.34
Tr1w
32.2%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

3
MetricValue
Operating Income
$921,424
Operating Income Growth
-29.3
Operating margin
16.99

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

9
MetricValue
Float
4,827,640%
Float Percent
28.1%
Net Borrowing
-156,351
Shares Insiders
71.9%
Shares Institutions
0.32%
Shares Out
17,178,000
Shares Qo Q
0%
Short Float
14.38%
Short Shares
4.04

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

44
MetricValue
Adjusted FCF
$401,264
Average Volume
874,469.63x
Bv Per Share
0.02
CAPEX
$-277,554
Ch1w
32.2
Change
-0.85%
Close
29.36
Depreciation Amortization
232,363
Earnings Date
2026-07-30
Earnings Time
bmo
EBIT
$921,424
EBITDA
$1.2M
EPS
$0.04
F Score
4
FCF
$401,264
FCF EV Yield
0.08x
FCF Per Share
$0.02
Financing CF
-456,892
Fiscal Year End
March
Founded
2,016
Graham Number
0.15001
Income Tax
$177,860
Investing CF
-1,146,607
Ipr
627.8
Iprfo
534.2
Is Primary Listing
1
Is Spac
No
Last Report Date
2025-09-30
Last Split Type
Never
Net CF
-917,816
Next Earnings Date
2026-05-22
Open
0
Optionable
No
P FCF Ratio
1,256.7
P OCF Ratio
742.9
Ppne
844,063
Price Date
2025-11-11
Price EBITDA
$437
Ptbv Ratio
1,408.7
Relative Volume
4.86x
Revenue
5,423,178x
Tax By Revenue
3.28x
Tax Rate
21.3%
Z Score
1.11
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does MCTA pay a dividend?

Capital-return profile for this ticker.

Ownership

Who owns MCTA?

Insider, institutional, and short-interest positioning.

Institutional ownership
+0.3%
Float: +28.1% of shares outstanding
Insider ownership
+71.9%
Stake held by company insiders. Higher generally signals alignment.
Short interest
+14.4%
Float sold short by bearish positioning
Y/Y dilution
n/a
Negative means the company is buying back shares.
Technical

MCTA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
81.3
Above 70: short-term overbought
Price vs 200-day MA
n/a
50/200-day relationship not available
Beta (5Y)
n/a
Sensitivity to the broader market
Sharpe ratio
9.50
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About MCTA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current MCTA stock rating?

Charming Medical Limited is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full MCTA analysis?

The full report lives at /stocks/MCTA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for MCTA?

The latest report frames MCTA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the MCTA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.